132 related articles for article (PubMed ID: 2800978)
1. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
Ording H
Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
[TBL] [Abstract][Full Text] [Related]
2. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
Bendixen D; Ording H
Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
[TBL] [Abstract][Full Text] [Related]
3. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
4. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Ording H; Skovgaard LT
Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
[TBL] [Abstract][Full Text] [Related]
5. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
Ording H; Skovgaard LT
Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590
[TBL] [Abstract][Full Text] [Related]
6. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
Ellis FR; Halsall PJ; Hopkins PM
Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
[TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
8. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Urwyler A; Censier K; Kaufmann MA; Drewe J
Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
[TBL] [Abstract][Full Text] [Related]
9. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
10. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
Ranklev E; Fletcher R; Blomquist S
Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
[TBL] [Abstract][Full Text] [Related]
11. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
[TBL] [Abstract][Full Text] [Related]
12. Halothane-caffeine contracture testing in neuromuscular diseases.
Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Hopkins PM; Ellis FR; Halsall PJ
Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
[TBL] [Abstract][Full Text] [Related]
14. Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Adamantidis MM; Reyford GH; Imbenotte M; Cordonnier C
Br J Anaesth; 1990 Dec; 65(6):791-5. PubMed ID: 1702303
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
16. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
[TBL] [Abstract][Full Text] [Related]
17. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
Ilias WK; Williams CH; Fulfer RT; Dozier SE
Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
20. Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?
Nelson TE; Flewellen EH
Can Anaesth Soc J; 1979 Nov; 26(6):484-8. PubMed ID: 526874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]